High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial
Crossref DOI link: https://doi.org/10.1007/s10549-015-3552-7
Published Online: 2015-08-29
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Callens, Céline
Debled, Marc
Delord, Marc
Turbiez-Stalain, Isabelle
Veyret, Corinne
Bièche, Ivan
Brain, Etienne
Text and Data Mining valid from 2015-08-29